JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harada, N.
Right arrow Articles by Katsuragi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harada, N.
Right arrow Articles by Katsuragi, T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL

Vol. 294, Issue 3, 1034-1042, September 2000

Adenosine and Selective A2A Receptor Agonists Reduce Ischemia/Reperfusion Injury of Rat Liver Mainly by Inhibiting Leukocyte Activation

Naoaki Harada, Kenji Okajima, Kazunori Murakami, Sadaharu Usune, Chiemi Sato, Koichi Ohshima and Takeshi Katsuragi

Department of Pharmacology (N.H., T.K.), Research Laboratory of Biodynamics (S.U., C.S.), and Department of Pathology (K.Oh.), School of Medicine, Fukuoka University, Fukuoka, Japan; and Department of Laboratory Medicine, Kumamoto University School of Medicine, Kumamoto, Japan (K.Ok., K.M.)

To examine whether adenosine reduces ischemia/reperfusion (I/R)-induced liver injury by inhibiting leukocyte activation via A2 receptor (A2R) stimulation, we investigated the effects of adenosine and selective A2A receptor (A2AR) agonists (YT-146 and CGS21680C) on I/R-induced liver injury in rats. Adenosine, YT-146, and CGS21680C, in the concentration of 10-7 to 10-5 M, significantly inhibited neutrophil elastase release by about 30 to 40% and increased intracellular Ca2+ concentrations in isolated neutrophils stimulated with formyl-methionyl-leucyl-phenylalanine (fMLP) in vitro. Adenosine, YT-146, and CGS21680C, in the concentration of 10-7 to 10-5 M, significantly inhibited tumor necrosis factor (TNF)-alpha production by monocytes stimulated with endotoxin by about 50%. Although ZM241385, a selective A2AR antagonist, significantly enhanced the increase in neutrophil elastase release and intracellular Ca2+ concentrations in neutrophils stimulated with fMLP, this agent did not affect the endotoxin-induced TNF-alpha production by monocytes. Rats were subjected to liver ischemia for 60 min. Serum levels of transaminases increased after hepatic I/R, peaking at 12 h after reperfusion. The i.v. infusion of adenosine (1 and 10 mg/kg/h), YT-146 (0.1 and 1 mg/kg/h), and CGS21680C (0.1 and 1 mg/kg/h) significantly inhibited the I/R-induced increase in serum transaminase levels 12 h after reperfusion. The I/R-induced decrease in hepatic tissue blood flow was significantly prevented by adenosine and YT-146. Hepatic levels of TNF-alpha , cytokine-induced neutrophil chemoattractant (equivalent to human interleukin-8), and myeloperoxidase were significantly increased after I/R. These increases were significantly inhibited by the administration of adenosine, YT-146, and CGS21680C. Although the histological neutrophil accumulation in the liver was significantly increased after I/R as evaluated by the naphthol AS-D chloroacetate technique, the administration of adenosine, YT-146, and CGS21680C significantly inhibited this increase. These findings suggest that adenosine reduces I/R-induced liver injury both by inhibiting the synthesis of inflammatory mediators and by inhibiting neutrophil degranulation directly, probably through A2AR stimulation.


0022-3565/00/2943-1034$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Yang, J. Linden, S. S. Berr, I. L. Kron, G. A. Beller, and B. A. French
Timing of adenosine 2A receptor stimulation relative to reperfusion has differential effects on infarct size and cardiac function as assessed in mice by MRI
Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2328 - H2335.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
V. L. Kolachala, R. Bajaj, M. Chalasani, and S. V. Sitaraman
Purinergic receptors in gastrointestinal inflammation
Am J Physiol Gastrointest Liver Physiol, February 1, 2008; 294(2): G401 - G410.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Mohsenin, T. Mi, Y. Xia, R. E. Kellems, J.-F. Chen, and M. R. Blackburn
Genetic removal of the A2A adenosine receptor enhances pulmonary inflammation, mucin production, and angiogenesis in adenosine deaminase-deficient mice
Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L753 - L761.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
T Konno, A Sato, T Uchibori, A Nagai, K Kogi, and N Nakahata
Adenosine A2A receptor mediated protective effect of 2-(6-cyano-1-hexyn-1-yl)adenosine on retinal ischaemia/reperfusion damage in rats
Br. J. Ophthalmol., July 1, 2006; 90(7): 900 - 905.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Z. Yang, Y.-J. Day, M.-C. Toufektsian, S. I. Ramos, M. Marshall, X.-Q. Wang, B. A. French, and J. Linden
Infarct-Sparing Effect of A2A-Adenosine Receptor Activation Is Due Primarily to Its Action on Lymphocytes
Circulation, May 3, 2005; 111(17): 2190 - 2197.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y.-J. Day, Y. Li, J. M. Rieger, S. I. Ramos, M. D. Okusa, and J. Linden
A2A Adenosine Receptors on Bone Marrow-Derived Cells Protect Liver from Ischemia-Reperfusion Injury
J. Immunol., April 15, 2005; 174(8): 5040 - 5046.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
K. Okajima, N. Harada, M. Uchiba, and M. Mori
Neutrophil elastase contributes to the development of ischemia-reperfusion-induced liver injury by decreasing endothelial production of prostacyclin in rats
Am J Physiol Gastrointest Liver Physiol, December 1, 2004; 287(6): G1116 - G1123.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
Y.-J. Day, M. A. Marshall, L. Huang, M. J. McDuffie, M. D. Okusa, and J. Linden
Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction
Am J Physiol Gastrointest Liver Physiol, February 1, 2004; 286(2): G285 - G293.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Gomez and M. V. Sitkovsky
Differential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivo
Blood, December 15, 2003; 102(13): 4472 - 4478.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
U. M. Hanumegowda, B. L. Copple, M. Shibuya, E. Malle, P. E. Ganey, and R. A. Roth
Basement Membrane and Matrix Metalloproteinases in Monocrotaline-Induced Liver Injury
Toxicol. Sci., November 1, 2003; 76(1): 237 - 246.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. B. Yee, U. M. Hanumegowda, J. A. Hotchkiss, P. E. Ganey, and R. A. Roth
Role of Neutrophils in the Synergistic Liver Injury from Monocrotaline and Bacterial Lipopolysaccharide Exposure
Toxicol. Sci., March 1, 2003; 72(1): 43 - 56.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. R. Morrison, M. A. H. Talukder, C. Ledent, and S. J. Mustafa
Cardiac effects of adenosine in A2A receptor knockout hearts: uncovering A2B receptors
Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H437 - H444.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.